Enhancing physician support in pancreatic cancer diagnosis: New M-F-RCNN artificial intelligence model using endoscopic ultrasound.

Background and study aims Endoscopic ultrasound (EUS) is vital for early pancreatic cancer diagnosis. Advances in artificial intelligence (AI), especially deep learning, have improved medical image analysis. We developed and validated the Modified Faster R-CNN (M-F-RCNN), an AI algorithm using EUS images to assist in diagnosing pancreatic cancer. Methods We collected EUS images from 155 patients across three endoscopy centers from July 2022 to July 2023. M-F-RCNN development involved enhancing feature information through data preprocessing and utilizing an improved Faster R-CNN model to identify cancerous regions. Its diagnostic capabilities were validated against an external set of 1,000 EUS images. In addition, five EUS doctors participated in a study comparing the M-F-RCNN model's performance with that of human experts, assessing diagnostic skill improvements with AI assistance. Results Internally, the M-F-RCNN model surpassed traditional algorithms with an average precision of 97.35%, accuracy of 96.49%, and recall rate of 5.44%. In external validation, its sensitivity, specificity, and accuracy were 91.7%, 91.5%, and 91.6%, respectively, outperforming non-expert physicians. The model also significantly enhanced the diagnostic skills of doctors. Conclusions: The M-F-RCNN model shows exceptional performance in diagnosing pancreatic cancer via EUS images, greatly improving diagnostic accuracy and efficiency, thus enhancing physician proficiency and reducing diagnostic errors.